Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2016 May 16;63(9):1608–1614. doi: 10.1002/pbc.26061

TABLE V.

Hearing Loss After Head and Neck Intensity Modulated Radiation Therapy for Pediatric Rhabdomyosarcoma

Tumor Site Tumor Laterality Hearing Loss Grade Hearing Loss Laterality Comments
1 Neck Left 2 Bilateral Received vincristine; no cisplatin or carboplatin
2 Skull base Left 2 Bilateral Right mixed hearing loss, left conductive hearing loss; received carboplatin and vincristine
3 Skull base Right 3 Unilateral Right conductive hearing loss; received carboplatin and vincristine
4 Infratemporal fossa Left 3 Unilateral Left mixed hearing loss; received carboplatin and vincristine
5 Skull base Left 3 Unilateral Requires left hearing aid; received cisplatin and vincristine
6 Infratemporal fossa Left 1 Bilateral Bilateral conductive hearing loss